insights_auto
Why is BOT down 5,26%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
0,018 A$
arrow_downward
-5,26%(-0,0010) 1D
2 հոկ, 14:44:13 GMT+10 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
0,02 A$
High
0,02 A$
Low
0,02 A$
Mkt. cap
44,74 մլն
Avg. vol.
6,30 մլն
Volume
2,15 մլն
52-wk high
0,17 A$
52-wk low
0,02 A$
EPS
-0,03 A$
Shares outstanding
2,76 մլրդ
No. of employees
11
Open
0,02 A$
High
0,02 A$
Low
0,02 A$
Mkt. cap
44,74 մլն
Avg. vol.
6,30 մլն
Volume
2,15 մլն
52-wk high
0,17 A$
52-wk low
0,02 A$
EPS
-0,03 A$
Shares outstanding
2,76 մլրդ
No. of employees
11
News stories
From web sources and news partners
Action Forex
·
35 րոպե առաջ
Elliott Wave Outlook: DOW Futures (Ym) Bearish Sequence Targets 49570
Simply Wall Street
·
1 ժամ առաջ
Axon Enterprise (AXON) Circles A Public Safety Deal As Sale Talks Emerge
TradingView
·
1 ժամ առաջ
Moderna to join Nasdaq-100, replacing Warner Bros. Discovery
Fox Business
·
7 ժամ առաջ
October could be a huge month for the stock market. Here's why.
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd